Literature DB >> 10067857

Human vascular endothelial cells express oxytocin receptors.

M Thibonnier1, D M Conarty, J A Preston, C L Plesnicher, R A Dweik, S C Erzurum.   

Abstract

Pharmacological studies in humans and animals suggest the existence of vascular endothelial vasopressin (AVP)/oxytocin (OT) receptors that mediate a vasodilatory effect. However, the nature of the receptor subtype(s) involved in this vasodilatory response remains controversial, and its coupled intracellular pathways are unknown. Thus, we set out to determine the type and signaling pathways of the AVP/OT receptor(s) expressed in human vascular endothelial cells (ECs). Saturation binding experiments with purified membranes of primary cultures of ECs from human umbilical vein (HUVEC), aorta (HAEC), and pulmonary artery (HPAEC) and [3H]AVP or [3H]OT revealed the existence of specific binding sites with a greater affinity for OT than AVP (Kd = 1.75 vs. 16.58 nM). Competition binding experiments in intact HUVECs (ECV304 cell line) with the AVP antagonist [125I]4-hydroxyphenacetyl-D-Tyr(Me)-Phe-Gln-Asn-Arg-Pro-Arg-NH2 or the OT antagonist [125I]D(CH2)5[O-Me-Tyr-Thr-Orn-Tyr-NH2]vasotocin, and various AVP/OT analogs confirmed the existence of a single class of surface receptors of the classical OT subtype. RT-PCR experiments with total RNA extracted from HUVEC, HAEC, and HPAEC and specific primers for the human V1 vascular, V2 renal, V3 pituitary, and OT receptors amplified the OT receptor sequence only. No new receptor subtype could be amplified when using degenerate primers. DNA sequencing of the coding region of the human EC OT receptor revealed a nucleotide sequence 100% homologous to that of the uterine OT receptor reported previously. Stimulation of ECs by OT produced mobilization of intracellular calcium and the release of nitric oxide that was prevented by chelation of extra- and intracellular calcium. No stimulation of cAMP or PG production was noted. Finally, OT stimulation of ECs led to a calcium- and protein kinase C-dependent cellular proliferation response. Thus, human vascular ECs express OT receptors that are structurally identical to the uterine and mammary OT receptors. These endothelial OT receptors produce a calcium-dependent vasodilatory response via stimulation of the nitric oxide pathway and have a trophic action.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10067857     DOI: 10.1210/endo.140.3.6546

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  63 in total

1.  Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells.

Authors:  A Tahara; J Tsukada; Y Tomura; K i Wada; T Kusayama; N Ishii; T Yatsu; W Uchida; A Tanaka
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

2.  CCK mediated the inhibitory effect of oxytocin on the contraction of longitudinal muscle strips of duodenum in male rats.

Authors:  Yinglian Lv; Mei Feng; Tongtong Che; Hui Sun; Yan Luo; Kejing Liu; Chuanyong Liu
Journal:  Pflugers Arch       Date:  2010-10-05       Impact factor: 3.657

3.  Deficits in plasma oxytocin responses and increased negative affect, stress, and blood pressure in mothers with cocaine exposure during pregnancy.

Authors:  Kathleen C Light; Karen M Grewen; Janet A Amico; Maria Boccia; Kimberly A Brownley; Josephine M Johns
Journal:  Addict Behav       Date:  2004-11       Impact factor: 3.913

4.  Bone marrow oxytocin mediates the anabolic action of estrogen on the skeleton.

Authors:  Graziana Colaianni; Li Sun; Adriana Di Benedetto; Roberto Tamma; Ling-Ling Zhu; Jay Cao; Maria Grano; Tony Yuen; Sylvia Colucci; Concetta Cuscito; Lucia Mancini; Jianhua Li; Katsuhiko Nishimori; Itai Bab; Heon-Jin Lee; Jameel Iqbal; W Scott Young; Clifford Rosen; Alberta Zallone; Mone Zaidi
Journal:  J Biol Chem       Date:  2012-07-02       Impact factor: 5.157

5.  Possible dynamic anchor points in a benzoxazinone derivative-human oxytocin receptor system--a molecular docking and dynamics calculation.

Authors:  Balázs Jójárt; Arpád Márki
Journal:  J Mol Model       Date:  2006-05-05       Impact factor: 1.810

6.  Regulation of the macrophage oxytocin receptor in response to inflammation.

Authors:  Angela Szeto; Ni Sun-Suslow; Armando J Mendez; Rosa I Hernandez; Klaus V Wagner; Philip M McCabe
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-01-03       Impact factor: 4.310

7.  Copeptin as a marker of relative arginine vasopressin deficiency after pediatric cardiac surgery.

Authors:  Christopher W Mastropietro; Meredith Mahan; Kevin M Valentine; Jeff A Clark; Patrick C Hines; Henry L Walters; Ralph E Delius; Ashok P Sarnaik; Noreen F Rossi
Journal:  Intensive Care Med       Date:  2012-10-24       Impact factor: 17.440

Review 8.  The oxytocin-bone axis.

Authors:  G Colaianni; R Tamma; A Di Benedetto; T Yuen; L Sun; M Zaidi; A Zallone
Journal:  J Neuroendocrinol       Date:  2014-02       Impact factor: 3.627

9.  Modulation of cardiac oxytocin receptor and estrogen receptor alpha mRNAs expression following neonatal oxytocin treatment.

Authors:  Hossein Pournajafi-Nazarloo; Eros Papademeteriou; Leila Partoo; Habibollah Saadat; Bruce S Cushing
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

10.  Central blockade of oxytocin receptors during mid-late gestation reduces amplitude of slow afterhyperpolarization in supraoptic oxytocin neurons.

Authors:  R Teruyama; D L Lipschitz; L Wang; G R Ramoz; W R Crowley; S L Bealer; W E Armstrong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-23       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.